Rheumatoid arthritis

Pregnancy outcomes in women with rheumatoid arthritis: an 11-year French nationwide study

RMD OpenPublished Retrospective cohort study

Authors' conclusion

Pregnancies in women with RA were associated with more adverse outcomes, especially if the disease was active.

Study context

Population
All pregnancies ending between 2010 and 2020 in patients with and without rheumatoid arthritis (RA), Francepregnancies
Exposure
RA pregnancies vs non-RA pregnancies; active vs non-active RA
  • RAn = 11,792
  • Non-RAn = 10,413,681reference
Outcome
Pregnancy outcomes, RA vs non-RA
Methodological detailsnationwide, French National Health Data System, multivariable logistic marginal regression with generalised estimating equation (GEE)
  • Nationwide
  • French National Health Data System
  • Multivariable logistic marginal regression with GEE

Main finding

As reported in the abstract

Each group vs Non-RAEstimate (95% CI)
RA
aOR, preterm birth 1.84(1.69–2.00)
RA
aOR, very preterm birth 1.43(1.20–1.71)
RA
aOR, low birth weight 1.65(1.52–1.90)
RA
aOR, caesarean section 1.46(1.38–1.55)
RA
aOR, pregnancy-related hospitalisation 1.30(1.22–1.39)

Observational data: associations, not effects.

Further findings

OutcomeEstimate
Pregnancy outcomes, active vs non-active RAActive RAvs Non-active RAaOR, prematurity 2.02 (95% CI 1.71–2.38)
Pregnancy outcomes, active vs non-active RAActive RAvs Non-active RAaOR, small for gestational age 1.53 (95% CI 1.28–1.83)
Pregnancy outcomes, active vs non-active RAActive RAvs Non-active RAaOR, caesarean section 1.25 (95% CI 1.11–1.40)

Outcomes of RA pregnancies

Live births
74.5%
Stillbirths
0.4%

Disease activity during pregnancy

Disease activity decreased during pregnancy

Original publication

Pregnancy outcomes in women with rheumatoid arthritis: an 11-year French nationwide study. RMD Open. Published 19 January 2024. doi:10.1136/rmdopen-2023-003762

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.